经口内镜下幽门肌切开术双肌切开与单肌切开治疗胃轻瘫的短期结局
双肌切开组临床应答率86%,单肌切开组67%,两组手术时间、术后疼痛、住院时间及不良事件无显著差异。
要点
- 两组手术时间、术后疼痛、住院时间和不良事件无显著差异。
- 双肌切开是安全可行的GPOEM技术,但需长期研究确认。
核心结论
- 双幽门肌切开在GPOEM中是安全可行的技术。
- 在这项非随机短期随访研究中,双肌切开组临床成功率高于单肌切开组。
- 需要长期研究进一步确认结果。
研究设计与样本
- 回顾性病例对照研究,纳入2015年6月至2018年3月在某三级医疗中心因难治性胃轻瘫接受GPOEM的患者。
- 因单肌切开组随访时间远长于双肌切开组,将单肌切开组随访时间匹配至双肌切开组。
- 平均年龄47±14岁,平均症状持续时间5.3±4.4年。
主要发现
- GPOEM前平均GCSI评分为3.8,术后6个月平均GCSI评分为1.8。
- 两组在手术时间、术后疼痛或住院时间方面无显著差异。
- 两组不良事件无差异。
关键数值与推荐
- 结局通过Gastroparesis Cardinal Symptom Index(GCSI)在术前与术后3至6个月的变化来测量。
临床怎么用
- 对于难治性胃轻瘫患者,GPOEM双幽门肌切开可作为安全可行的选择,短期临床应答率高于单肌切开。
- 临床决策时需注意证据来自非随机短期随访研究,长期疗效待确认。
局限性
- 非随机研究设计。
- 短期随访。
- 单中心回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The prevalence of gastroparesis (Gp), a chronic debilitating disorder, and resulting hospitalizations are increasing. Gastric peroral endoscopic pyloromyotomy (POP or GPOEM) is a novel technique in the treatment of refractory Gp. Despite the initial promising results of GPOEM, one-third of patients do not exhibit any clinical response. Furthermore, loss of clinical response was reported in several studies. No response or loss of response after GPOEM may be related to inadequate myotomy. The aim of our study is to examine whether double pyloromyotomy at GPOEM is superior to single pyloromyotomy. METHOD: A retrospective case-controlled study of patients who underwent GPOEM for refractory Gp at our tertiary care institution between June 2015 and March 2018 was performed. Because the follow-up time for the single myotomy group was much longer than that of the double myotomy group, we matched the length of follow-up for the single myotomy group to that of the double myotomy group. The outcomes were measured by the changes in the Gastroparesis Cardinal Symptom Index (GCSI) before and 3 to 6 months after the procedure. Adverse events and other procedural and clinical parameters were also compared. RESULTS: Ninety patients underwent GPOEM (55 single and 35 double pyloromyotomy). The mean age was 47 ± 14 years, and the mean duration of symptoms was 5.3 ± 4.4 years. The average GCSI score was 3.8 before the GPOEM, and the average GCSI score 6 months after procedure was 1.8. Thirty-seven of 55 (67%) patients who underwent single pyloromyotomy achieved clinical response compared with 30 of 35 (86%) patients who underwent double pyloromyotomy. There were no significant differences for procedure time, postoperative pain, or length of hospital stay between the 2 groups. There was no difference in adverse events in the 2 pyloromyotomy groups. CONCLUSION: Double pyloromyotomy is a safe and feasible technique during GPOEM. Clinical success was higher in patients undergoing double pyloromyotomy compared with single pyloromyotomy in this nonrandomized, short-term follow-up study. Long-term studies are needed to further confirm our results.
引用
- Abdelfatah MM, Li B, Kapil N, et al. Short-term outcomes of double versus single pyloromyotomy at peroral endoscopic pyloromyotomy in the treatment of gastroparesis (with video). Gastrointest Endosc. 2020. PMID: 31958460. doi:10.1016/j.gie.2020.01.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。